Class information for:
Level 1: BISOPROLOL//CARDIOSELECTIVE BETA BLOCKERS//CARDIOSELECTIVE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
20710 388 30.9 62%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
895 10656 CARVEDILOL//NEBIVOLOL//BETA BLOCKERS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BISOPROLOL Author keyword 9 18% 12% 45
2 CARDIOSELECTIVE BETA BLOCKERS Author keyword 1 50% 1% 2
3 CARDIOSELECTIVE Author keyword 1 40% 1% 2
4 NW EXCELLENCE Address 1 40% 1% 2
5 AINTREE CARDIAC Address 1 19% 1% 4
6 BETA AR BLOCKERS Author keyword 1 50% 0% 1
7 BETA1 SELECTIVE BLOCKER Author keyword 1 50% 0% 1
8 BLOOD PRESSURE AT REST Author keyword 1 50% 0% 1
9 BRONCHIAL RELAXATION Author keyword 1 50% 0% 1
10 CARDIOL SECT CARDIOL Address 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 BISOPROLOL 9 18% 12% 45 Search BISOPROLOL Search BISOPROLOL
2 CARDIOSELECTIVE BETA BLOCKERS 1 50% 1% 2 Search CARDIOSELECTIVE+BETA+BLOCKERS Search CARDIOSELECTIVE+BETA+BLOCKERS
3 CARDIOSELECTIVE 1 40% 1% 2 Search CARDIOSELECTIVE Search CARDIOSELECTIVE
4 BETA AR BLOCKERS 1 50% 0% 1 Search BETA+AR+BLOCKERS Search BETA+AR+BLOCKERS
5 BETA1 SELECTIVE BLOCKER 1 50% 0% 1 Search BETA1+SELECTIVE+BLOCKER Search BETA1+SELECTIVE+BLOCKER
6 BLOOD PRESSURE AT REST 1 50% 0% 1 Search BLOOD+PRESSURE+AT+REST Search BLOOD+PRESSURE+AT+REST
7 BRONCHIAL RELAXATION 1 50% 0% 1 Search BRONCHIAL+RELAXATION Search BRONCHIAL+RELAXATION
8 CARDIOVASCULAR EVENT PREVENTION 1 50% 0% 1 Search CARDIOVASCULAR+EVENT+PREVENTION Search CARDIOVASCULAR+EVENT+PREVENTION
9 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MANAGEMENT 1 50% 0% 1 Search CHRONIC+OBSTRUCTIVE+PULMONARY+DISEASE+MANAGEMENT Search CHRONIC+OBSTRUCTIVE+PULMONARY+DISEASE+MANAGEMENT
10 CO EXISTANT DISEASE 1 50% 0% 1 Search CO+EXISTANT+DISEASE Search CO+EXISTANT+DISEASE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BETA 1 SELECTIVE ADRENOCEPTOR ANTAGONIST 8 100% 1% 5
2 BETA 1 SELECTIVITY 6 100% 1% 4
3 FATAL BRONCHOSPASM 4 67% 1% 4
4 MURINE ASTHMA MODEL 2 22% 2% 7
5 CARDIOSELECTIVE BETA BLOCKERS 1 33% 1% 3
6 CATECHOLAMINES FOLLOWING EXERCISE 1 50% 0% 1
7 FOREARM ARTERIES 1 50% 0% 1
8 II CIBIS II 1 50% 0% 1
9 ISCHEMIC BURDEN BISOPROLOL 1 50% 0% 1
10 ORAL NADOLOL 1 50% 0% 1

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Role of beta-blockers in patients with COPD: current perspective 2015 1 50 46%
Beta-blocker use and COPD mortality: a systematic review and meta-analysis 2012 22 19 42%
Heart Failure and Chronic Obstructive Pulmonary Disease 2011 51 87 37%
Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure 2012 7 27 59%
POPULATION PHARMACOKINETIC ANALYSIS OF BISOPROLOL 1989 13 8 75%
beta-Blockers and Chronic Obstructive Pulmonary Disease: Inappropriate Avoidance? 2013 6 41 41%
Adverse Respiratory Effect of Acute beta-Blocker Exposure in Asthma A Systematic Review and Meta-analysis of Randomized Controlled Trials 2014 1 39 41%
Cardioselective beta-blockers for chronic obstructive pulmonary disease 2005 76 63 43%
Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis 2003 59 44 39%
BISOPROLOL - IS THIS JUST ANOTHER BETA-BLOCKER FOR HYPERTENSION OR ANGINA 1995 12 51 71%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 NW EXCELLENCE 1 40% 0.5% 2
2 AINTREE CARDIAC 1 19% 1.0% 4
3 CARDIOL SECT CARDIOL 1 50% 0.3% 1
4 INTERNAL MED P MED CARDIOL 1 50% 0.3% 1
5 KRANKENHAUS BAD OEYNHAUSEN 1 50% 0.3% 1
6 PHARMACOL CARDIOL 1 50% 0.3% 1
7 QUAL SAFETY IMPROVEMENT GRP 1 50% 0.3% 1
8 SZIVGYOGYASZATI KLIN 1 50% 0.3% 1
9 BEIJING CARDIOVASC RECEPTORS 1 29% 0.5% 2
10 FSB EDUC SCI MED 0 33% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000244397 CELIPROLOL//BEVANTOLOL//PERINDOPRIL THERAPEUTIC USE
2 0.0000183991 RECEPTOR OCCUPANCY THEORY//DIACETOLOL//TERNARY COMPLEX MODEL
3 0.0000152679 NEBIVOLOL//VASODILATING BETA BLOCKERS//NEBIVOLOL HYDROCHLORIDE
4 0.0000128325 ADR MONITORING//BOVINE BRONCHI//ACE I INHIBITOR
5 0.0000127225 ALPHA BETA ADRENOCEPTOR BLOCKADE//KMUP 1//EUGENOSEDIN A
6 0.0000121898 COLLATERAL CORONARY FLOW//ADV MED TRAINING STATE//BETA BLOCKER
7 0.0000119533 CARVEDILOL//BUCINDOLOL//CARVEDILOL ENANTIOMERS
8 0.0000117674 COPD//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
9 0.0000116437 AMOSULALOL//TERTATOLOL//DILEVALOL
10 0.0000102922 T 0509//ZINTEROL//BETA ADRENERGIC RECEPTOR SUBTYPE